Clinical trial
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B…
NCT00289770 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00289770 |
|---|---|
| Title | Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults |
| Official title | A Double Blind Randomised, Comparative Study of the Immunogenicity and Reactogenicity of Three Different Lots of GlaxoSmithKline Biologicals' Combined Hepatitis A - Hepatitis B Vaccine When Administered in Healthy Adults |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Hepatitis A |
| Intervention type | Biological |
| Interventions | Twinrix™ |
| Enrollment | 50 |
| Start date | Nov 1, 2004 |
| Primary completion | Dec 20, 2004 |
| Completion | Dec 20, 2004 |
| First posted | Feb 10, 2006 |
| Last update posted | Aug 17, 2018 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: